UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Accelerated approval of multiple myeloma therapies

Cancer, 2024-08, Vol.130 (16), p.2732-2732

Nierengarten, Mary Beth

2024

Link zum Volltext

Verfügbarkeit prüfen

The value of myocardial contraction fraction and long-axis strain to predict late gadolinium enhancement in multiple myeloma patients with secondary cardiac amyloidosis

Scientific reports, 2024-07, Vol.14 (1), p.16832-10, Article 16832

2024

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions

Pharmaceuticals (Basel, Switzerland), 2024-07, Vol.17 (7), p.901

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma

Blood cancer journal (New York), 2024-07, Vol.14 (1), p.122-9, Article 122

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma

Cancer medicine (Malden, MA), 2024-07, Vol.13 (14), p.e7435-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma

Blood cancer journal (New York), 2024-07, Vol.14 (1), p.117-12, Article 117

2024

Link zum Volltext

Verfügbarkeit prüfen

Joint AI-driven event prediction and longitudinal modeling in newly diagnosed and relapsed multiple myeloma

NPJ digital medicine, 2024-07, Vol.7 (1), p.200, Article 200

2024

Link zum Volltext

Verfügbarkeit prüfen

Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study

Journal of the Formosan Medical Association, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

IgG replacement in multiple myeloma

Blood cancer journal (New York), 2024-07, Vol.14 (1), p.124-9, Article 124

2024

Link zum Volltext

Verfügbarkeit prüfen

Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

Blood cancer journal (New York), 2024-07, Vol.14 (1), p.111-9, Article 111

2024

Link zum Volltext

Verfügbarkeit prüfen

New Combination-Based Approaches to NDMM: What Do the Data, the Experts, and Patients Say?

Oncology (Williston Park, N.Y.), 2024-06, Vol.38 (6), p.244

2024

Link zum Volltext

Verfügbarkeit prüfen

First person profile: Heather A. Wakelee, MD: For more than 20 years, she has served in multiple functions, including developing research programs in lung cancer and thymoma that include clinical trials and population science approaches

Cancer, 2024-08, Vol.130 (16), p.2730-2730

Nierengarten, Mary Beth

2024

Link zum Volltext

Verfügbarkeit prüfen

Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment

Frontiers in oncology, 2024-07, Vol.14

2024

Link zum Volltext

Verfügbarkeit prüfen

Class Ⅱ ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma

Blood advances, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of concurrent renal impairment at diagnosis of multiple myeloma: a systematic review

Annals of medicine (Helsinki), 2024-12, Vol.56 (1), p.2380301

2024

Link zum Volltext

Verfügbarkeit prüfen

Continued Success of Venetoclax in t

Oncology (Williston Park, N.Y.), 2024-06, Vol.38 (6), p.239

2024

Link zum Volltext

Verfügbarkeit prüfen

MULTIDISCIPLINARY CARE

Oncology (Williston Park, N.Y.), 2024-06, Vol.38 (6), p.241

2024

Link zum Volltext

Verfügbarkeit prüfen

Osteolytic mystery: A rare case of pathologic fracture from a phosphaturic mesenchymal tumor in hip and femur

Radiology case reports, 2024-10, Vol.19 (10), p.4413-4416

2024

Link zum Volltext

Verfügbarkeit prüfen

Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma

International journal of molecular sciences, 2024-07, Vol.25 (14), p.7795

2024

Link zum Volltext

Verfügbarkeit prüfen

A rare case of multiple myeloma with several atypical manifestations

Italian journal of medicine, 2024-07, Vol.18 (3)

2024

Link zum Volltext

Verfügbarkeit prüfen

The SAR analysis of dietary polyphenols and their antagonistic effects on bortezomib at physiological concentrations

Frontiers in pharmacology, 2024-07, Vol.15

2024

Link zum Volltext

Verfügbarkeit prüfen

Identification and prognostic analysis of metabolic genes associated with TP53 mutation in multiple myeloma

Hematology (Luxembourg), 2024-12, Vol.29 (1), p.2377850

2024

Link zum Volltext

Verfügbarkeit prüfen

The efficacy and safety of second salvage autologous transplantation in myeloma patients

Pathology oncology research, 2024-07, Vol.30, p.1611851

2024

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review

Frontiers in oncology, 2024-07, Vol.14, p.1390747

2024

Link zum Volltext

Verfügbarkeit prüfen

A.R.R.O.W.2: Once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Blood advances, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 30 Tagen

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(60)
magazinearticle
(1)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood Cancer Journal
(5)
Cancer Medicine
(4)
International Journal Of Molecular Sciences
(3)
Oncology
(3)
Blood Advances
(2)
Cancer
(2)
Cancers
(2)
Frontiers In Oncology
(2)
Hematology
(2)
Journal Of Clinical Medicine
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Accelerated approval of multiple myeloma therapies

The value of myocardial contraction fraction and long-axis strain to predict late gadolinium enhancement in multiple myeloma patients with secondary cardiac amyloidosis

Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions

Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma

Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma

Joint AI-driven event prediction and longitudinal modeling in newly diagnosed and relapsed multiple myeloma

Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study

IgG replacement in multiple myeloma

Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

New Combination-Based Approaches to NDMM: What Do the Data, the Experts, and Patients Say?

First person profile: Heather A. Wakelee, MD: For more than 20 years, she has served in multiple functions, including developing research programs in lung cancer and thymoma that include clinical trials and population science approaches

Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment

Class Ⅱ ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma

Prognosis of concurrent renal impairment at diagnosis of multiple myeloma: a systematic review

Continued Success of Venetoclax in t

MULTIDISCIPLINARY CARE

Osteolytic mystery: A rare case of pathologic fracture from a phosphaturic mesenchymal tumor in hip and femur

Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma

A rare case of multiple myeloma with several atypical manifestations

The SAR analysis of dietary polyphenols and their antagonistic effects on bortezomib at physiological concentrations

Identification and prognostic analysis of metabolic genes associated with TP53 mutation in multiple myeloma

The efficacy and safety of second salvage autologous transplantation in myeloma patients

Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review

A.R.R.O.W.2: Once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Aktive Filter

Suchergebnisse filtern